DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search

• URL: http://arxiv.org/abs/2507.07426v3
• Date: Thu, 31 Jul 2025 13:57:25 GMT
• Title: DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search
• Authors: Zerui Yang, Yuwei Wan, Siyu Yan, Yudai Matsuda, Tong Xie, Bram Hoex, Linqi Song,
• Abstract summary: DrugMCTS is a novel framework that integrates RAG, multi-agent collaboration, and Monte Carlo Tree Search for drug repositioning.<n>It employs five specialized agents tasked with retrieving and analyzing molecular and protein information, thereby enabling structured and iterative reasoning.<n>Our results highlight the importance of structured reasoning, agent-based collaboration, and feedback-driven search mechanisms.
• Score: 10.123162419093973
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Recent advances in large language models have demonstrated considerable potential in scientific domains such as drug repositioning. However, their effectiveness remains constrained when reasoning extends beyond the knowledge acquired during pretraining. Conventional approaches, such as fine-tuning or retrieval-augmented generation, face limitations in either imposing high computational overhead or failing to fully exploit structured scientific data. To overcome these challenges, we propose DrugMCTS, a novel framework that synergistically integrates RAG, multi-agent collaboration, and Monte Carlo Tree Search for drug repositioning. The framework employs five specialized agents tasked with retrieving and analyzing molecular and protein information, thereby enabling structured and iterative reasoning. Extensive experiments on the DrugBank and KIBA datasets demonstrate that DrugMCTS achieves substantially higher recall and robustness compared to both general-purpose LLMs and deep learning baselines. Our results highlight the importance of structured reasoning, agent-based collaboration, and feedback-driven search mechanisms in advancing LLM applications for drug repositioning.

Related papers

• DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery [11.588325823566827]
  DrugPilot is a large-scale language model with parameterized reasoning for drug discovery.<n>It supports major phases of the drug discovery pipeline, facilitating automated planning and execution of research tasks.<n>It achieves task completion rates of 98.0%, 93.5%, and 64.0% on simple, multiple, and multi-turn tasks, respectively.
  arXiv  Detail & Related papers  (2025-05-20T05:18:15Z)
• LLM Agent Swarm for Hypothesis-Driven Drug Discovery [2.7036595757881323]
  PharmaSwarm is a unified multi-agent framework that orchestrates specialized "agents" to propose, validate, and refine hypotheses for novel drug targets and lead compounds.<n>By acting as an AI copilot, PharmaSwarm can accelerate translational research and deliver high-confidence hypotheses more efficiently than traditional pipelines.
  arXiv  Detail & Related papers  (2025-04-24T22:27:50Z)
• Addressing Model Overcomplexity in Drug-Drug Interaction Prediction With Molecular Fingerprints [0.0]
  Accurately predicting drug-drug interactions (DDIs) is crucial for pharmaceutical research and clinical safety.<n>Recent deep learning models often suffer from high computational costs and limited generalization across datasets.<n>In this study, we investigate a simpler yet effective approach using molecular representations such as Morgan fingerprints (S), graph-based embeddings from graph convolutional networks (GCNs), and transformer-derived embeddings from MoLFormer integrated into a straightforward neural network.
  arXiv  Detail & Related papers  (2025-03-30T18:27:01Z)
• PharmAgents: Building a Virtual Pharma with Large Language Model Agents [19.589707628042422]
  We introduce PharmAgents, a virtual pharmaceutical ecosystem driven by multi-agent collaboration.<n>The system integrates explainable, LLM-driven agents equipped with specialized machine learning models and computational tools.<n>It identifies potential therapeutic targets, discovers promising lead compounds, enhances binding affinity and key molecular properties, and performs in silico analyses of toxicity and synthetic feasibility.
  arXiv  Detail & Related papers  (2025-03-28T06:02:53Z)
• ReMA: Learning to Meta-think for LLMs with Multi-Agent Reinforcement Learning [53.817538122688944]
  We introduce Reinforced Meta-thinking Agents (ReMA) to elicit meta-thinking behaviors from Reasoning of Large Language Models (LLMs)<n>ReMA decouples the reasoning process into two hierarchical agents: a high-level meta-thinking agent responsible for generating strategic oversight and plans, and a low-level reasoning agent for detailed executions.<n> Empirical results from single-turn experiments demonstrate that ReMA outperforms single-agent RL baselines on complex reasoning tasks.
  arXiv  Detail & Related papers  (2025-03-12T16:05:31Z)
• RAG-Enhanced Collaborative LLM Agents for Drug Discovery [28.025359322895905]
  CLADD is a retrieval-augmented generation (RAG)-empowered agentic system tailored to drug discovery tasks.<n>We show that it outperforms general-purpose and domain-specific LLMs as well as traditional deep learning approaches.
  arXiv  Detail & Related papers  (2025-02-22T00:12:52Z)
• DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration [24.65716292347949]
  DrugAgent is a multi-agent framework that automates machine learning (ML) programming for drug discovery tasks.<n>Our results show that DrugAgent consistently outperforms leading baselines.
  arXiv  Detail & Related papers  (2024-11-24T03:06:59Z)
• Large Language Models in Drug Discovery and Development: From Disease Mechanisms to Clinical Trials [49.19897427783105]
  The integration of Large Language Models (LLMs) into the drug discovery and development field marks a significant paradigm shift. We investigate how these advanced computational models can uncover target-disease linkage, interpret complex biomedical data, enhance drug molecule design, predict drug efficacy and safety profiles, and facilitate clinical trial processes.
  arXiv  Detail & Related papers  (2024-09-06T02:03:38Z)
• DrugAgent: Multi-Agent Large Language Model-Based Reasoning for Drug-Target Interaction Prediction [8.98329812378801]
  DrugAgent is a multi-agent system for drug-target interaction prediction.<n>It combines multiple specialized perspectives with transparent reasoning.<n>Our approach provides detailed, human-interpretable reasoning for each prediction.
  arXiv  Detail & Related papers  (2024-08-23T21:24:59Z)
• Retrieval-Enhanced Machine Learning: Synthesis and Opportunities [60.34182805429511]
  Retrieval-enhancement can be extended to a broader spectrum of machine learning (ML) This work introduces a formal framework of this paradigm, Retrieval-Enhanced Machine Learning (REML), by synthesizing the literature in various domains in ML with consistent notations which is missing from the current literature. The goal of this work is to equip researchers across various disciplines with a comprehensive, formally structured framework of retrieval-enhanced models, thereby fostering interdisciplinary future research.
  arXiv  Detail & Related papers  (2024-07-17T20:01:21Z)
• SeRTS: Self-Rewarding Tree Search for Biomedical Retrieval-Augmented Generation [50.26966969163348]
  Large Language Models (LLMs) have shown great potential in the biomedical domain with the advancement of retrieval-augmented generation (RAG) Existing retrieval-augmented approaches face challenges in addressing diverse queries and documents, particularly for medical knowledge queries. We propose Self-Rewarding Tree Search (SeRTS) based on Monte Carlo Tree Search (MCTS) and a self-rewarding paradigm.
  arXiv  Detail & Related papers  (2024-06-17T06:48:31Z)
• Drug Synergistic Combinations Predictions via Large-Scale Pre-Training and Graph Structure Learning [82.93806087715507]
  Drug combination therapy is a well-established strategy for disease treatment with better effectiveness and less safety degradation. Deep learning models have emerged as an efficient way to discover synergistic combinations. Our framework achieves state-of-the-art results in comparison with other deep learning-based methods.
  arXiv  Detail & Related papers  (2023-01-14T15:07:43Z)
• SSM-DTA: Breaking the Barriers of Data Scarcity in Drug-Target Affinity Prediction [127.43571146741984]
  Drug-Target Affinity (DTA) is of vital importance in early-stage drug discovery. wet experiments remain the most reliable method, but they are time-consuming and resource-intensive. Existing methods have primarily focused on developing techniques based on the available DTA data, without adequately addressing the data scarcity issue. We present the SSM-DTA framework, which incorporates three simple yet highly effective strategies.
  arXiv  Detail & Related papers  (2022-06-20T14:53:25Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.